Clinical Trials List
Protocol NumberDB2116960
Not yet recruiting
2013-07-01 - 2015-12-31
Phase III
Terminated3
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 方文豐 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 秦建弘 Division of Thoracic Medicine
- 吳沼漧 Division of Thoracic Medicine
- 陳永哲 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- 黃國棟 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 梁深怡 Division of Thoracic Medicine
- 陳泓丞 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shuo-Chueh Chen Division of Thoracic Medicine
- Wei-Chun Chen Division of Thoracic Medicine
- 梁信杰 Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- 陳鴻仁 Division of Thoracic Medicine
- Chen Chia-Hung Division of Thoracic Medicine
- Te-Chun Shen Division of Thoracic Medicine
- Chih-Ching Yen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming -Cheng Chan Division of Thoracic Medicine
- Wei- Chang Huang Division of Thoracic Medicine
- 王振宇 Division of Thoracic Medicine
- 覃俊士 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
666 participants
